/Baxter%20International%20Inc_%20logo%20on%20building-by%20JHVEPhoto%20via%20Shutterstock.jpg)
With a market cap of $10.3 billion, Baxter International Inc. (BAX) provides a broad portfolio of medical products, pharmaceuticals, and healthcare technologies used across hospitals, clinics, and home care settings. Operating through three segments: Medical Products and Therapies; Healthcare Systems and Technologies; and Pharmaceuticals, it serves patients and providers worldwide through an extensive international presence and distribution network.
The Deerfield, Illinois-based company is expected to unveil its fiscal Q4 2025 results soon. Ahead of the event, analysts forecast BAX to post an adjusted EPS of $0.53, a decline of 8.6% from $0.58 in the same quarter last year. It has surpassed Wall Street's bottom-line projections in three of the past four quarters while missing on another occasion.
